Design and synthesis of a cocaine-diamide hapten for vaccine development

Tetrahedron Letters

Volumn 37, Issue 31, 1996, Pages 5479-5482

  Sakurai, Mitsuya ^a   Wirsching, Peter ^a   Janda, Kim D ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE DERIVATIVE; HAPTEN; VACCINE;

ARTICLE; DRUG ABUSE; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; PREVENTION;

EID: 0030605861     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/0040-4039(96)01170-7     Document Type: Article

References (31)

1. 1. (a) National Institute on Drug Abuse, Division of Epidemiology and Prevention Research. National Household Survey on Drug Abuse: Population Estimates 1990. Rockville, MD: U. S. Department of Health and Human Services, 1991.
2. (b) Blaine, J. D.; Ling, W. Psychopharmacol. Bull. 1992, 28, 11.
3. 2. Withers, N. W.; Pulvirenti, L.; Koob, G. F.; Gillin, J. C. J. Clin. Psychopharmacol. 1995, 15, 63.
4. 3. Rosecan, J. S.; Spitz, H. I. In: Cocaine Abuse: New Directions in Treatment and Research. Spitz, H. I.; Rosecan, J. S., eds.; New York: Brunner/Mazel, 1987.
5. 4. (a) Roberts, D. C. S.; Koob, G. F. Pharmacol. Biochem. Behav. 1982, 17, 901.
6. (b) Pettit, H. O.; Ettenberg, A.; Bloom, F. E.; Koob, G. F. Psychopharmacology 1984, 84, 167.
7. (c) Roberts, D. C. S.; Vickers, G. Psychopharmacology 1984, 82, 135.
8. 5. Ritz, M. C.; Lamb, R. J.; Goldberg, S. R.; Kuhar, M. J. Science 1987, 237, 1219.
9. 6. (a) Carroll, F. I.; Gray, J. L.; Abraham, P.; Kuzemko, M. A.; Lewin, A. H.; Boja, J. W.; Kuhar, M. J. J. Med. Chem. 1993, 36, 2886.
10. (b) Davies, H. M. L.; Saikali, E.; Huby, N. J. S.; Gilliartt, V. J.; Matasi, J. J.; Sexton, T.; Childers, S. R. J. Med. Chem. 1994, 37, 1262.
11. (c) Kelkar, S. V.; Izenwasser, S.; Katz, J. L.; Klein, C. L.; Zhu, N.; Trudell, M. L. J. Med. Chem. 1994, 37, 3875.
12. (d) Kozikowski, A. P.; Saiah, M. K. E.; Johnson, K. M., Bergman, J. S. J. Med. Chem. 1995, 38, 3086.
13. (e) Neumeyer, J. L.; Tamagnan, G.; Wang, S.; Gao, Y.; Milius, R. A.; Kula, N. S.; Baldessarini, R. J. J. Med. Chem. 1996, 39, 543, and references cited therein.
14. 7. Hall, W. C.; Talbert, R. L.; Ereshefsky, L. Pharmacotherapy 1990, 10, 46.
15. 8. (a) Berkowitz, B.; Spector, S. Science 1972, 178, 1290.
16. (b) Spector, S.; Berkowitz, B.; Flynn, E. J.; Peskar, B. Pharmacol. Rev. 1973, 25, 281.
17. 9. Landry, D. W.; Zhao, K.; Yang, G. X.-Q.; Glickman, M.; Georgiadis, T. M. Science 1993, 259, 1899.
18. 10. Carrera, M. Rocio A.; Ashley, J. A.; Parsons, L. H.; Wirsching, P.; Koob, G. F.; Janda, K. D. Nature 1995, 378, 727.
19. 11. Sinnema, A.; Maat, L.; van der Gugten, A. J.; Beyerman, H. C. Recl. Trav. Chim. Pays-Bas 1968, 87, 1027.
20. 12. Liotta, C. L.; Grisdale, E. E.; Hopkins, H. P. J. Tetrahedron Lett. 1975, 4205.
21. 13. Zirkle, C. L.; Geissman, T. A.; Bloom, M.; Craig, P. N.; Gerns, F. R.; Indik, Z. K.; Pavloff, A. M. J. Org. Chem. 1962, 27, 1269.
22. 14. Lal, B.; Pramanik, B.N.; Manhas, M.S.; Bose, A.K., Tetrahedron Lett. 1977, 1977.
23. 15. (a) Findlay, S. P. J. Am. Chem. Soc. 1953, 75, 4624.
24. (b) Findlay, S. P. J. Am. Chem. Soc. 1954, 76, 2855.
25. 16. (a) Findlay, S. P., J. Org. Chem. 1957, 22, 1385. The (+)-isomer corresponds to the configuration of the desired natural (-)-cocaine framework.
26. (b) Carroll, F. I.; Coleman, M. L.; Lewin, A. H. J. Org. Chem. 1982, 47, 13. These workers report an alternative large scale preparation of racemic 7.
27. (c) Lewin, A. H.; Naseree, T.; Carroll, F. I. J. Heterocyclic Chem. 1987, 24, 19.
28. (d) Meltzer, P. C.; Liang, A. Y.; Madras, B. K. J. Med. Chem. 1994, 37, 2001.
29. 17. Baraldi, P. G.; Simoni, D.; Manfredini, S. Synthesis 1983, 902.
30. 18. Borch, R. F.; Bernstein, M. D.; Durst, H. D. J. Am. Chem. Soc. 1971, 93, 2897.
31. 16d of the optical rotations of (1R)-7 and (1S)-7. In our hands, a value of +26.6° was found for the R isomer that could only be obtained for a solution observed within 4 minutes of preparation. We found that aged solutions in methanol had lesser rotations (absolute value) due to epimerization at C-2. For (1R)-7, an equilibrium value of +17.4° was attained after 30 minutes. Hence, we compared this value to that for material having 99% ee.